Gene therapy and CRISPR strategies for curing blindness (Yes, you read that right) – Boston Business Journal

dnasplicing_1200xx6000-3375-0-313

Written by Hemant Khanna

In recent months, even as our attention has been focused on the coronavirus outbreak, there have been a slew of scientific breakthroughs in treating diseases that cause blindness.

Researchers at U.S.-based Editas Medicine and Ireland-based Allergan …

By Jessica Yap-Chung
Jessica Yap-Chung Profile Picture
Read more »

CVS launching platform to help employers, universities safely reopen amid COVID-19 – Fierce Healthcare

Screen Shot 2020-06-26 at 10.05.52 AM

Written by Paige Minemyer

CVS Health is the latest company to launch a solution aimed at helping employers and university campuses safely reopen amid COVID-19.

The Return Ready solution offers employers and colleges the ability to customize a testing and …

By Jessica Yap-Chung
Jessica Yap-Chung Profile Picture
Read more »

Judge wipes out Biogen’s Tecfidera patent protections in suit against Mylan – FiercePharma

biogen

Written by Eric Sagonowsky

In the high-stakes patent fight between Biogen and Mylan over Tecfidera’s main remaining patent, Mylan has scored a major win in federal court.

U.S. District Judge Irene Keeley said Mylan “demonstrated by clear and convincing evidence” that …

By Jessica Yap-Chung
Jessica Yap-Chung Profile Picture
Read more »

Pear Therapeutics Announces Market Authorization of reset from the Health Science Authority in Singapore for the Treatment of Adults with Substance Use Disorder – Pear Therapeutics

pear therapeutics

Sourced from Pear Therapeutics

BOSTON and SAN FRANCISCO, June 18, 2020 — Pear Therapeutics, Inc. today announced that the Health Science Authority (HSA) of Singapore has authorized reSET® for the treatment of adults with substance use disorder (SUD) in that country. This …

By Jessica Yap-Chung
Jessica Yap-Chung Profile Picture
Read more »

Akili Announces FDA Clearance of EndeavorRx™ for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game – Akili Interactive

akili interactive

Sourced from Akili Interactive

BOSTON, Mass – June 15, 2020 – Akili today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRxTM (AKL-T01) as a prescription treatment for children with attention-deficit/hyperactivity disorder (ADHD). Delivered through a captivating video game experience, EndeavorRx is indicated …

By Jessica Yap-Chung
Jessica Yap-Chung Profile Picture
Read more »